How Prostatic Neoplasms Medications Work

Prostatic neoplasms, or prostate cancer, is a complex and multifaceted disease that requires a comprehensive treatment approach. While surgery remains the gold standard for treating localized prostate cancer, various medications can be used to manage symptoms, slow disease progression, and improve quality of life.

Mechanism of Action

• Hormone Therapy: Medications such as LHRH agonists (e.g., leuprolide) or antagonists (e.g., abarelix) can reduce testosterone levels, which can slow the growth and spread of prostate cancer cells.

• Chemotherapy: Agents like docetaxel or cabazitaxel work by interfering with cell division, ultimately leading to cell death. This approach is often used in combination with hormone therapy for advanced disease.

• Radiation Therapy: While not a medication per se, radiation can be delivered via external beam radiation (EBRT) or brachytherapy, which involves implanting radioactive seeds directly into the prostate gland. Radiation damages DNA, preventing cancer cells from dividing and growing.

Goals of Treatment

The primary goals of treating prostatic neoplasms with medications are to:

• Control symptoms: Relieve urinary obstruction, pain, and other symptoms associated with advanced disease.

• Slow disease progression: Delay the growth and spread of cancer cells, improving survival rates and quality of life.